Galectin 9 Polyclonal Antibody
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bs-1699R |
| Product Name | Galectin 9 Polyclonal Antibody |
| Applications |
WB
ELISA
FCM
IF(IHC-F)
|
| Reactivity | Human, Mouse |
| Predicted Reactivity | Rat, Cow, Pig |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from mouse Galectin |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 3965 |
| Subcellular location | Cytoplasm, Secreted |
| Synonyms | Ecalectin; galectin9; HOM HD 21; HOMHD21; HUAT; Lectin galactoside binding soluble 9; LGAL S9; LGALS 9; LGALS9; LGALS9A; MGC117375; MGC125973; MGC125974 ; Urate transporter/channel protein; Galectin-9; Gal-9. |
| Background | The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin 9 is an S-type lectin and an eosinophil chemoattractant (ECA) produced by antigen-activated T cells. Galectin 9 is involved in apoptosis, is thought to be a prognostic factor for breast cancer and is also overexpressed in Hodgkin's disease tissue. The protein has N- and C- terminal carbohydrate-binding domains connected by a link peptide. Multiple alternatively spliced transcript variants have been found for this gene. |
| Application Dilution | |
| WB | 1:300-5000 |
| ELISA | 1:500-1000 |
| FCM | 1:20-100 |
| IF(IHC-F) | 1:50-200 |